Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Subscribe To Our Newsletter & Stay Updated